Tech Company Financing Transactions
PrimeraDx Funding Round
PrimeraDx closed a $21 million Series B funding round on 1/8/2008. Investors included Abingworth, Burrill & Company and MPM Capital.
Transaction Overview
Company Name
Announced On
1/8/2008
Transaction Type
Venture Equity
Amount
$21,000,000
Round
Series B
Investors
Abingworth (Lead Investor) (Vincent Miles)
Burrill & Company (Ann Hanham)
MPM Capital (Kazumi Shiosaki)
Proceeds Purpose
"Primera plans to use this financing to complete development of our instrument system, reagent kits for disease-specific clinical research, future diagnostic tests as well as support ongoing research and development efforts," said Martin L. Verhoef, President and Chief Executive Officer of Primera Biosystems, Inc.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
171 Forbes Blvd. 1000
Mansfield, MA 02048
USA
Mansfield, MA 02048
USA
Phone
Website
Email Address
Overview
Primera is developing a proprietary gene expression analysis system, STAR (Scalable Transcription Analysis Routine) that combines into a single system the desirable features of both real-time PCR and DNA microarray technologies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Matthew McManus
Chief Financial Officer
Ted Myles
Chief Scientific Officer
Lilly Kong
VP - Bus. Development
David Jackson
VP - Engineering
David Heffelfinger
VP - Regulatory Affairs
Fayyaz Memon
Browse more venture capital transactions:
Prev: 1/8/2008: Mogulus venture capital transaction
Next: 1/8/2008: Check venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC transactions reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs